Synthetic Cathinone-Induced Myocarditis and Psychosis: A Case Report

J Addict Med. 2023 Mar-Apr;17(2):e135-e137. doi: 10.1097/ADM.0000000000001056. Epub 2022 Aug 24.

Abstract

Psychoactive substances are a diverse group of chemical substances that are ever-evolving structurally. Novel psychoactive substances are being reported in and are becoming increasingly popular in East and Southeast Asia, with synthetic cathinones becoming the drugs of choice. The use of synthetic cathinones has increased significantly over the years. However, the easy accessibility of these substances and their potentially damaging health effects have raised many concerns. Herein, we present the case of a patient who ingested mixed synthetic cathinones and eventually developed acute myocarditis and subsequent psychotic symptoms. The delayed presentation of psychosis coupled with initial cardiovascular symptoms was a unique phenomenon, making differential diagnosis challenging. The association between the use of synthetic cathinones and psychosis and myocarditis should be explored in view of the lack of relevant clinical data and potentially dire outcomes.

Publication types

  • Case Reports

MeSH terms

  • Alkaloids* / adverse effects
  • Central Nervous System Stimulants*
  • Humans
  • Myocarditis* / chemically induced
  • Myocarditis* / diagnosis
  • Psychotic Disorders* / drug therapy
  • Synthetic Cathinone

Substances

  • Synthetic Cathinone
  • Alkaloids
  • Central Nervous System Stimulants